X

Trial Profile

A Phase 2b Trial to Evaluate the Efficacy and Safety of BLS-ILB-E710c in Patients With Cervical Intraepithelial Neoplasia 2/3 (CIN2/3)

Status: Recruiting

Phase of Trial: Phase II

Latest Information Update: 02 Feb 2022

Price :

$35 ^*

Note:

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

Drugs Human papillomavirus vaccine (Primary)
Indications Cervical intraepithelial neoplasia; Human papillomavirus infections
Focus Therapeutic Use
Sponsors Bioleaders Corporation

Most Recent Events

06 Feb 2020 Planned End Date changed from 31 Dec 2018 to 1 Aug 2020.
06 Feb 2020 Planned primary completion date changed from 31 Oct 2018 to 1 Aug 2020.
04 Apr 2018 Planned End Date changed from 31 Aug 2019 to 31 Dec 2018.

You need to be a logged in or subscribed to view this content Request demo

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com